A case of community-acquired Acinetobacter baumannii meningitis - has the threat moved beyond the hospital?

J Med Microbiol. 2008 May;57(Pt 5):676-678. doi: 10.1099/jmm.0.47781-0.

Abstract

Acinetobacter baumannii is a prolific nosocomial pathogen renowned for its multidrug-resistant nature. We report a case of community-acquired meningitis due to A. baumannii. The case highlights the potential pathogenicity of this organism and raises concerns that this highly adaptable organism may soon evolve into a significant community pathogen, too.

Publication types

  • Case Reports

MeSH terms

  • Acinetobacter Infections / diagnosis
  • Acinetobacter Infections / epidemiology
  • Acinetobacter Infections / microbiology*
  • Acinetobacter baumannii / isolation & purification*
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Inflammatory Agents / therapeutic use
  • Ceftriaxone / therapeutic use
  • Community-Acquired Infections / epidemiology
  • Community-Acquired Infections / microbiology
  • Cross Infection / epidemiology
  • Cross Infection / microbiology
  • Dexamethasone / therapeutic use
  • Humans
  • Male
  • Meningitis, Bacterial / diagnosis
  • Meningitis, Bacterial / epidemiology
  • Meningitis, Bacterial / microbiology*
  • Meropenem
  • Middle Aged
  • Thienamycins / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Thienamycins
  • Ceftriaxone
  • Dexamethasone
  • Meropenem